BioNTech at Cell 2026
Nov 12–13, 2026 London, UK ~800 attendees Website
BioNTech takes part in 2 sessions at Cell 2026 in London. Its sessions look at the future of advanced therapies and at the rules taking shape for them. The specific focus is new regulatory guidance for gene therapies made for individual patients.
| Organization | Cell 2026 Attendance |
|---|---|
BioNTech Mainz, Germany | |
Develops mRNA vaccines and immunotherapies, including cell therapies and antibodies, mainly for cancer and infectious disease. | Panel Thu Nov 12 3:05pm–3:30pm Talk Fri Nov 13 4:15pm–4:40pm Emerging Regulatory Guidelines For Individualised Gene Therapies Cell and gene therapy |
Instantly find 20 buyers from BioNTech
Get a list of who you should contact, their contact info, and what to say.
Totally free and instant, no sign up necessary!
Not affiliated with or endorsed by Cell 2026 or its organizers. Submit a correction